INFLAMMATIX
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University. The company was founded by Timothy Sweeney and Jonathan Romanowsky in California.
INFLAMMATIX
Industry:
Big Data Bioinformatics Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.inflammatix.com
Total Employee:
51+
Status:
Active
Contact:
650-443-3030
Email Addresses:
[email protected]
Total Funding:
137.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
CareDx
CareDx is a novel molecular diagnostics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Inflammatix
OSF Ventures
OSF Ventures investment in Series D - Inflammatix
D1 Capital Partners
D1 Capital Partners investment in Series D - Inflammatix
Think.Health
Think.Health investment in Series D - Inflammatix
Northpond Ventures
Northpond Ventures investment in Series D - Inflammatix
Khosla Ventures
Khosla Ventures investment in Series D - Inflammatix
DARPA
DARPA investment in Grant - Inflammatix
Northpond Ventures
Northpond Ventures investment in Series C - Inflammatix
Grey Sky Venture Partners
Grey Sky Venture Partners investment in Series C - Inflammatix
Khosla Ventures
Khosla Ventures investment in Series C - Inflammatix
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-15 | Inflammatix Appoints Purvesh Khatri as Chief Scientific Officer |
| 2021-04-15 | Inflammatix Appoints Amy Boyle as Chief Operating Officer |
Official Site Inspections
http://www.inflammatix.com Semrush global rank: 4.62 M Semrush visits lastest month: 2.17 K
- Host name: 34.0.153.160.host.secureserver.net
- IP address: 160.153.0.34
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
